Theorem Clinical Research Appoints SVP

Marc Hoffman, M.D. has joined Theorem Clinical Research as senior vice president and general manager for the company’s newly formed Pharmaceutical Development Business Unit. Dr. Hoffman will have strategic oversight for Theorem’s CRO operation, including project management, clinical monitoring, SMART (Site Management And Patient RecruitmenT), and Pharmaceutics. He will also oversee the company’s Medical Operations.
 
“With more than 20 years of experience across both the CRO and pharmaceutical industries, Marc has an intense understanding of the drug development process, as well as how to run clinical trials on-time and on-budget,” said John Potthoff, Ph.D., president and chief executive officer of Theorem. “Under his leadership, I believe our core CRO business will thrive and continue to differentiate itself as a global, specialized team dedicated to delivering positive outcomes on our clients’ behalf.”

Most recently, Dr. Hoffman served as the vice president of Medical and Scientific Affairs for Covance. Prior to Covance, he worked in various clinical development, medical affairs and regulatory roles for companies including Hospira, Baxter Healthcare, Kendle and Parexel.